✦ LIBER ✦

EVALUATION OF THE EFFICACY AND SAFETY OF OTAMIXABAN VS. UNFRACTIONATED HEPARIN+EPTIFIBATIDE IN ELDERLY PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES IN THE SEPIA-ACS1 TIMI 42 TRIAL

✍ Scribed by Christian T. Ruff; Shaun Goodman; Hanoch Hod; Christoph Bode; Petr Widimsky; Robert G. Kiss; Charles F. Contant; Sharon E. Crugnale; Angele Moryusef; Gabriel Steg; Elliott M. Antman; Marc S. Sabatine

Book ID: 118581721
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 292 KB
Volume: 57
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(11)60915-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Otamixaban for the treatment of patients

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial

✍ Marc S Sabatine; Elliott M Antman; Petr Widimsky; Iftikhar O Ebrahim; Robert G K 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 247 KB

Randomized evaluation of the safety and

Randomized evaluation of the safety and efficacy of enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

✍ S.G. Goodman; D. Fitchett; P.W. Armstrong; M. Tan; A. Langer 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Safety and efficacy of enoxaparin vs. un

Safety and efficacy of enoxaparin vs. unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes. who receive tirofiban and aspirin

✍ M.A. Blazing; J.A. de Lemos; H.D. White 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Safety and Efficacy of Enoxaparin vs Unf

Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and AspirinA Randomized Controlled Trial

✍ Blazing, Michael A. 📂 Article 📅 2004 🏛 American Medical Association 🌐 English ⚖ 180 KB

Design and rationale of the Treatment of

Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy

✍ Philippe Gabriel Steg; Shamir R. Mehta; Charles V. Pollack Jr.; Christoph Bode; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 398 KB

PCV49 ENOXAPARIN VERSUS UNFRACTIONATED H

PCV49 ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR THE NONINVASIVE MANAGEMENT OF PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES (NSTE-ACS): THE PHARMACOECONOMIC EVALUATION IN RUSSIA

✍ A Syrov; S Zyryanov; YB Belousov 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB